Arrowhead Pharmaceuticals, Inc.
ARWR
$-0.03
Change (1 day)
$39.83
Year High
$18.15
Year Low
Categories
Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, which is in phase 2b and one phase 3 clinical trial to treat hypertriglyceridemia; ARO-ANG3 that is in Phase 2b clinical trial to reduce production of angiopoietin-like protein 3; ARO-HSD, which is in Phase 1/2a clinical trial to treat liver diseases; ARO-ENaC, which is in a Phase 1/2a clinical trial to reduce production of the epithelial sodium channel alpha subunit in the airways of the lung; ARO-C3 for the treatment of complement-mediated disease that is in Phase 1/2a clinical trial; ARO-Lung2 for the treatment of chronic obstructive pulmonary disorder; ARO-DUX4 for the treatment of facioscapulohumeral muscular dystrophy; ARO-XDH to treat uncontrolled gout; ARO-COV for the treatment of COVID-19 and other pulmonary-borne pathogens; and ARO-HIF2, which is in phase 1b clinical trial to treat clear cell renal cell carcinoma. It is also involved in the development of JNJ-3989, a subcutaneously administered RNAi therapeutic candidate to treat chronic hepatitis B virus infection; Olpasiran to reduce the production of apolipoprotein A; and ARO-AMG1 for treating genetically validated cardiovascular targets. Arrowhead Pharmaceuticals, Inc. has a license and research collaboration agreement with Janssen Pharmaceuticals, Inc. to develop ARO-JNJ1, ARO-JNJ2, and ARO-JNJ3 RNAi therapeutics for liver-expressed targets; and license and research collaboration agreement with Takeda Pharmaceuticals U.S.A., Inc. to develop RNAi therapeutic candidate as a treatment for liver disease. Arrowhead Pharmaceuticals, Inc. was incorporated in 1989 and is headquartered in Pasadena, California.
Market capitalization of Arrowhead Pharmaceuticals, Inc. (ARWR)
Market cap: $2.34 B
As of Oct 2024 Arrowhead Pharmaceuticals, Inc. has a market cap of $2.34 B. This makes Arrowhead Pharmaceuticals, Inc. the world's most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of Arrowhead Pharmaceuticals, Inc. from 2001 to 2023
Market Cap History
| Date | Market cap |
|---|---|
| 04 Oct 2024 | $2.34 B |
| 03 Oct 2024 | $2.34 B |
| 02 Oct 2024 | $2.39 B |
| 01 Oct 2024 | $2.38 B |
| 30 Sep 2024 | $2.41 B |
| 27 Sep 2024 | $2.44 B |
| 26 Sep 2024 | $2.44 B |
| 25 Sep 2024 | $2.41 B |
| 24 Sep 2024 | $2.5 B |
| 23 Sep 2024 | $2.48 B |
| 20 Sep 2024 | $2.58 B |
| 19 Sep 2024 | $2.63 B |
| 18 Sep 2024 | $2.58 B |
| 17 Sep 2024 | $2.49 B |
| 16 Sep 2024 | $2.54 B |
| 13 Sep 2024 | $2.67 B |
| 12 Sep 2024 | $2.51 B |
| 11 Sep 2024 | $2.6 B |
| 10 Sep 2024 | $2.67 B |
| 09 Sep 2024 | $2.7 B |
| 06 Sep 2024 | $2.76 B |
| 05 Sep 2024 | $2.89 B |
| 04 Sep 2024 | $2.98 B |
| 03 Sep 2024 | $2.85 B |
| 30 Aug 2024 | $2.96 B |
| 29 Aug 2024 | $2.99 B |
| 28 Aug 2024 | $2.97 B |
| 27 Aug 2024 | $2.97 B |
| 26 Aug 2024 | $3.07 B |
| 23 Aug 2024 | $3.08 B |
| 22 Aug 2024 | $3.03 B |
| 21 Aug 2024 | $3.13 B |
| 20 Aug 2024 | $2.93 B |
| 19 Aug 2024 | $2.9 B |
| 16 Aug 2024 | $2.82 B |
| 15 Aug 2024 | $2.81 B |
| 14 Aug 2024 | $2.82 B |
| 13 Aug 2024 | $2.84 B |
| 12 Aug 2024 | $2.85 B |
| 09 Aug 2024 | $2.91 B |
| 08 Aug 2024 | $3.21 B |
| 07 Aug 2024 | $3.1 B |
| 06 Aug 2024 | $3.21 B |
| 05 Aug 2024 | $3.11 B |
| 02 Aug 2024 | $3.23 B |
| 01 Aug 2024 | $3.39 B |
| 31 Jul 2024 | $3.52 B |
| 30 Jul 2024 | $3.52 B |
| 29 Jul 2024 | $3.53 B |
| 26 Jul 2024 | $3.48 B |
| 25 Jul 2024 | $3.57 B |
| 24 Jul 2024 | $3.56 B |
| 23 Jul 2024 | $3.55 B |
| 22 Jul 2024 | $3.54 B |
| 19 Jul 2024 | $3.49 B |
| 18 Jul 2024 | $3.41 B |
| 17 Jul 2024 | $3.45 B |
| 16 Jul 2024 | $3.64 B |
| 15 Jul 2024 | $3.56 B |
| 12 Jul 2024 | $3.47 B |
| 11 Jul 2024 | $3.48 B |
| 10 Jul 2024 | $3.31 B |
| 09 Jul 2024 | $3.13 B |
| 08 Jul 2024 | $3.15 B |
| 05 Jul 2024 | $3.15 B |
| 03 Jul 2024 | $3.09 B |
| 02 Jul 2024 | $3.11 B |
| 01 Jul 2024 | $3.21 B |
| 28 Jun 2024 | $3.2 B |
| 27 Jun 2024 | $3.17 B |
| 26 Jun 2024 | $3.24 B |
| 25 Jun 2024 | $3.31 B |
| 24 Jun 2024 | $3.36 B |
| 21 Jun 2024 | $3.14 B |
| 20 Jun 2024 | $2.93 B |
| 18 Jun 2024 | $2.91 B |
| 17 Jun 2024 | $3.09 B |
| 14 Jun 2024 | $3.19 B |
| 13 Jun 2024 | $3.27 B |
| 12 Jun 2024 | $3.18 B |
| 11 Jun 2024 | $3.04 B |
| 10 Jun 2024 | $3.02 B |
| 07 Jun 2024 | $2.95 B |
| 06 Jun 2024 | $3.04 B |
| 05 Jun 2024 | $3.11 B |
| 04 Jun 2024 | $3.12 B |
| 03 Jun 2024 | $3.04 B |
| 31 May 2024 | $2.83 B |
| 30 May 2024 | $2.81 B |
| 29 May 2024 | $2.82 B |
| 28 May 2024 | $2.95 B |
| 24 May 2024 | $3.07 B |
| 23 May 2024 | $3.04 B |
| 22 May 2024 | $3.1 B |
| 21 May 2024 | $3.08 B |
| 20 May 2024 | $3.06 B |
| 17 May 2024 | $3.05 B |
| 16 May 2024 | $3.08 B |
| 15 May 2024 | $3.09 B |
| 14 May 2024 | $2.82 B |
| 13 May 2024 | $2.72 B |
| 10 May 2024 | $2.72 B |
| 09 May 2024 | $3.05 B |
| 08 May 2024 | $3.11 B |
| 07 May 2024 | $3.08 B |
| 06 May 2024 | $3.1 B |
| 03 May 2024 | $2.63 B |
| 02 May 2024 | $2.59 B |
| 01 May 2024 | $2.49 B |
| 30 Apr 2024 | $2.43 B |
| 29 Apr 2024 | $2.48 B |
| 26 Apr 2024 | $2.38 B |
| 25 Apr 2024 | $2.35 B |
| 24 Apr 2024 | $2.5 B |
| 23 Apr 2024 | $2.55 B |
| 22 Apr 2024 | $2.57 B |
| 19 Apr 2024 | $2.4 B |
| 18 Apr 2024 | $2.43 B |
| 17 Apr 2024 | $2.42 B |
| 16 Apr 2024 | $2.54 B |
| 15 Apr 2024 | $2.58 B |
| 12 Apr 2024 | $2.65 B |
| 11 Apr 2024 | $2.76 B |
| 10 Apr 2024 | $2.73 B |
| 09 Apr 2024 | $2.82 B |
| 08 Apr 2024 | $2.76 B |
| 05 Apr 2024 | $2.77 B |
| 04 Apr 2024 | $2.8 B |
| 03 Apr 2024 | $2.84 B |
| 02 Apr 2024 | $2.81 B |
| 01 Apr 2024 | $3.03 B |
| 28 Mar 2024 | $3.07 B |
| 27 Mar 2024 | $3.08 B |
| 26 Mar 2024 | $2.99 B |
| 25 Mar 2024 | $3 B |
| 22 Mar 2024 | $2.92 B |
| 21 Mar 2024 | $3.03 B |
| 20 Mar 2024 | $3.02 B |
| 19 Mar 2024 | $2.98 B |
| 18 Mar 2024 | $3.02 B |
| 15 Mar 2024 | $3.04 B |
| 14 Mar 2024 | $2.95 B |
| 13 Mar 2024 | $3.07 B |
| 12 Mar 2024 | $3.07 B |
| 11 Mar 2024 | $3.16 B |
| 08 Mar 2024 | $3.59 B |
| 07 Mar 2024 | $3.57 B |
| 06 Mar 2024 | $3.8 B |
| 05 Mar 2024 | $3.66 B |
| 04 Mar 2024 | $3.77 B |
| 01 Mar 2024 | $3.88 B |
| 29 Feb 2024 | $3.45 B |
| 28 Feb 2024 | $3.65 B |
| 27 Feb 2024 | $3.35 B |
| 26 Feb 2024 | $3.28 B |
| 23 Feb 2024 | $3.39 B |
| 22 Feb 2024 | $3.24 B |
| 21 Feb 2024 | $3.13 B |
| 20 Feb 2024 | $3.14 B |
| 16 Feb 2024 | $3.17 B |
| 15 Feb 2024 | $3.18 B |
| 14 Feb 2024 | $3.18 B |
| 13 Feb 2024 | $3.21 B |
| 12 Feb 2024 | $3.47 B |
| 09 Feb 2024 | $3.5 B |
| 08 Feb 2024 | $3.31 B |
| 07 Feb 2024 | $3.4 B |
| 06 Feb 2024 | $3.57 B |
| 05 Feb 2024 | $3.44 B |
| 02 Feb 2024 | $3.43 B |
| 01 Feb 2024 | $3.46 B |
| 31 Jan 2024 | $3.45 B |
| 30 Jan 2024 | $3.55 B |
| 29 Jan 2024 | $3.7 B |
| 26 Jan 2024 | $3.52 B |
| 25 Jan 2024 | $3.59 B |
| 24 Jan 2024 | $3.52 B |
| 23 Jan 2024 | $3.68 B |
| 22 Jan 2024 | $3.57 B |
| 19 Jan 2024 | $3.63 B |
| 18 Jan 2024 | $3.56 B |
| 17 Jan 2024 | $3.66 B |
| 16 Jan 2024 | $3.77 B |
| 12 Jan 2024 | $3.91 B |
| 11 Jan 2024 | $4.03 B |
| 10 Jan 2024 | $4.24 B |
| 09 Jan 2024 | $4.09 B |
| 08 Jan 2024 | $4.24 B |
| 05 Jan 2024 | $3.82 B |
| 04 Jan 2024 | $3.71 B |
| 03 Jan 2024 | $3.43 B |
| 02 Jan 2024 | $3.33 B |
| 29 Dec 2023 | $3.29 B |
| 28 Dec 2023 | $3.33 B |
| 27 Dec 2023 | $3.33 B |
| 26 Dec 2023 | $3.32 B |
| 22 Dec 2023 | $3.26 B |
| 21 Dec 2023 | $3.09 B |
| 20 Dec 2023 | $2.99 B |
| 19 Dec 2023 | $3.22 B |
| 18 Dec 2023 | $3 B |
| 15 Dec 2023 | $3.07 B |
| 14 Dec 2023 | $3.07 B |
| 13 Dec 2023 | $2.89 B |
| 12 Dec 2023 | $2.65 B |
| 11 Dec 2023 | $2.56 B |
| 08 Dec 2023 | $2.57 B |
| 07 Dec 2023 | $2.63 B |
| 06 Dec 2023 | $2.56 B |
| 05 Dec 2023 | $2.52 B |
| 04 Dec 2023 | $2.68 B |
| 01 Dec 2023 | $2.49 B |
| 30 Nov 2023 | $2.28 B |
| 29 Nov 2023 | $3.11 B |
| 28 Nov 2023 | $3.11 B |
| 27 Nov 2023 | $3.08 B |
| 24 Nov 2023 | $3.13 B |
| 22 Nov 2023 | $3.11 B |
| 21 Nov 2023 | $3.05 B |
| 20 Nov 2023 | $3.1 B |
| 17 Nov 2023 | $3.01 B |
| 16 Nov 2023 | $2.8 B |
| 15 Nov 2023 | $2.9 B |
| 14 Nov 2023 | $2.94 B |
| 13 Nov 2023 | $2.79 B |
| 10 Nov 2023 | $2.9 B |
| 09 Nov 2023 | $2.87 B |
| 08 Nov 2023 | $2.91 B |
| 07 Nov 2023 | $2.95 B |
| 06 Nov 2023 | $2.89 B |
| 03 Nov 2023 | $3.02 B |
| 02 Nov 2023 | $2.81 B |
| 01 Nov 2023 | $2.77 B |
| 31 Oct 2023 | $2.64 B |
| 30 Oct 2023 | $2.49 B |
| 27 Oct 2023 | $2.53 B |
| 26 Oct 2023 | $2.62 B |
| 25 Oct 2023 | $2.58 B |
| 24 Oct 2023 | $2.69 B |
| 23 Oct 2023 | $2.65 B |
| 20 Oct 2023 | $2.73 B |
| 19 Oct 2023 | $2.72 B |
| 18 Oct 2023 | $2.79 B |
| 17 Oct 2023 | $2.9 B |
| 16 Oct 2023 | $2.85 B |
| 13 Oct 2023 | $2.86 B |
| 12 Oct 2023 | $2.78 B |
| 11 Oct 2023 | $2.84 B |
| 10 Oct 2023 | $2.75 B |
| 09 Oct 2023 | $2.68 B |
| 06 Oct 2023 | $2.71 B |
| 05 Oct 2023 | $2.74 B |
| 04 Oct 2023 | $2.55 B |
| 03 Oct 2023 | $2.7 B |
| 02 Oct 2023 | $2.82 B |
| 29 Sep 2023 | $2.88 B |
| 28 Sep 2023 | $2.89 B |
| 27 Sep 2023 | $2.83 B |
| 26 Sep 2023 | $2.81 B |
| 25 Sep 2023 | $2.86 B |
| 22 Sep 2023 | $2.92 B |
| 21 Sep 2023 | $2.92 B |
| 20 Sep 2023 | $2.9 B |
| 19 Sep 2023 | $2.92 B |
| 18 Sep 2023 | $3.02 B |
| 15 Sep 2023 | $3.1 B |
| 14 Sep 2023 | $3.28 B |
| 13 Sep 2023 | $3.15 B |
| 12 Sep 2023 | $3.12 B |
| 11 Sep 2023 | $3.14 B |
| 08 Sep 2023 | $3.21 B |
| 07 Sep 2023 | $3.24 B |
| 06 Sep 2023 | $3.14 B |
| 05 Sep 2023 | $3.01 B |
| 01 Sep 2023 | $3 B |
| 31 Aug 2023 | $2.97 B |
| 30 Aug 2023 | $2.88 B |
| 29 Aug 2023 | $2.91 B |
| 28 Aug 2023 | $2.97 B |
| 25 Aug 2023 | $3 B |
| 24 Aug 2023 | $3.01 B |
| 23 Aug 2023 | $3.07 B |
| 22 Aug 2023 | $3.05 B |
| 21 Aug 2023 | $3.08 B |
| 18 Aug 2023 | $3.03 B |
| 17 Aug 2023 | $3.11 B |
| 16 Aug 2023 | $3.11 B |
| 15 Aug 2023 | $3.15 B |
| 14 Aug 2023 | $3.15 B |
| 11 Aug 2023 | $3.1 B |
| 10 Aug 2023 | $3.11 B |
| 09 Aug 2023 | $3.11 B |
| 08 Aug 2023 | $2.95 B |
| 07 Aug 2023 | $3.31 B |
| 04 Aug 2023 | $3.4 B |
| 03 Aug 2023 | $3.47 B |
| 02 Aug 2023 | $3.54 B |
| 01 Aug 2023 | $3.61 B |
| 31 Jul 2023 | $3.7 B |
| 28 Jul 2023 | $3.77 B |
| 27 Jul 2023 | $3.84 B |
| 26 Jul 2023 | $3.77 B |
| 25 Jul 2023 | $3.82 B |
| 24 Jul 2023 | $3.76 B |
| 21 Jul 2023 | $3.87 B |
| 20 Jul 2023 | $3.74 B |
| 19 Jul 2023 | $3.71 B |
| 18 Jul 2023 | $3.75 B |
| 17 Jul 2023 | $3.72 B |
| 14 Jul 2023 | $3.71 B |
| 13 Jul 2023 | $3.7 B |
| 12 Jul 2023 | $3.64 B |
| 11 Jul 2023 | $3.68 B |
| 10 Jul 2023 | $3.65 B |
| 07 Jul 2023 | $3.58 B |
| 06 Jul 2023 | $3.71 B |
| 05 Jul 2023 | $3.77 B |
| 03 Jul 2023 | $3.78 B |
| 30 Jun 2023 | $3.83 B |
| 29 Jun 2023 | $3.84 B |
| 28 Jun 2023 | $3.95 B |
| 27 Jun 2023 | $3.86 B |
| 26 Jun 2023 | $3.76 B |
| 23 Jun 2023 | $3.77 B |
| 22 Jun 2023 | $3.8 B |
| 21 Jun 2023 | $3.8 B |
| 20 Jun 2023 | $3.83 B |
| 16 Jun 2023 | $3.79 B |
| 15 Jun 2023 | $3.82 B |
| 14 Jun 2023 | $3.78 B |
| 13 Jun 2023 | $3.77 B |
| 12 Jun 2023 | $3.79 B |
| 09 Jun 2023 | $3.78 B |
| 08 Jun 2023 | $3.82 B |
| 07 Jun 2023 | $3.9 B |
| 06 Jun 2023 | $3.86 B |
| 05 Jun 2023 | $3.75 B |
| 02 Jun 2023 | $3.86 B |
| 01 Jun 2023 | $3.71 B |
| 31 May 2023 | $3.68 B |
| 30 May 2023 | $3.51 B |
| 26 May 2023 | $3.6 B |
| 25 May 2023 | $3.59 B |
| 24 May 2023 | $3.81 B |
| 23 May 2023 | $3.88 B |
| 22 May 2023 | $3.91 B |
| 19 May 2023 | $3.88 B |
| 18 May 2023 | $3.88 B |
| 17 May 2023 | $3.97 B |
| 16 May 2023 | $4.03 B |
| 15 May 2023 | $4.27 B |
| 12 May 2023 | $4.21 B |
| 11 May 2023 | $4.29 B |
| 10 May 2023 | $4.33 B |
| 09 May 2023 | $4.33 B |
| 08 May 2023 | $4.33 B |
| 05 May 2023 | $4.43 B |
| 04 May 2023 | $4.29 B |
| 03 May 2023 | $4.3 B |
| 02 May 2023 | $3.79 B |
| 01 May 2023 | $3.82 B |
| 28 Apr 2023 | $3.79 B |
| 27 Apr 2023 | $3.74 B |
| 26 Apr 2023 | $3.8 B |
| 25 Apr 2023 | $3.59 B |
| 24 Apr 2023 | $3.21 B |
| 21 Apr 2023 | $3.3 B |
| 20 Apr 2023 | $3.2 B |
| 19 Apr 2023 | $3.26 B |
| 18 Apr 2023 | $3.25 B |
| 17 Apr 2023 | $3.35 B |
| 14 Apr 2023 | $3.26 B |
| 13 Apr 2023 | $3.26 B |
| 12 Apr 2023 | $3.06 B |
| 11 Apr 2023 | $2.81 B |
| 10 Apr 2023 | $2.73 B |
| 06 Apr 2023 | $2.8 B |
| 05 Apr 2023 | $2.7 B |
| 04 Apr 2023 | $2.69 B |
| 03 Apr 2023 | $2.74 B |
| 31 Mar 2023 | $2.72 B |
| 30 Mar 2023 | $2.61 B |
| 29 Mar 2023 | $2.64 B |
| 28 Mar 2023 | $2.59 B |
| 27 Mar 2023 | $2.61 B |
| 24 Mar 2023 | $2.59 B |
| 23 Mar 2023 | $2.53 B |
| 22 Mar 2023 | $2.53 B |
| 21 Mar 2023 | $2.63 B |
| 20 Mar 2023 | $2.68 B |
| 17 Mar 2023 | $2.59 B |
| 16 Mar 2023 | $2.61 B |
| 15 Mar 2023 | $2.7 B |
| 14 Mar 2023 | $2.84 B |
| 13 Mar 2023 | $2.82 B |
| 10 Mar 2023 | $2.81 B |
| 09 Mar 2023 | $2.96 B |
| 08 Mar 2023 | $3.17 B |
| 07 Mar 2023 | $3.26 B |
| 06 Mar 2023 | $3.29 B |
| 03 Mar 2023 | $3.45 B |
| 02 Mar 2023 | $3.46 B |
| 01 Mar 2023 | $3.49 B |
| 28 Feb 2023 | $3.45 B |
| 27 Feb 2023 | $3.48 B |
| 24 Feb 2023 | $3.48 B |
| 23 Feb 2023 | $3.5 B |
| 22 Feb 2023 | $3.51 B |
| 21 Feb 2023 | $3.39 B |
| 17 Feb 2023 | $3.6 B |
| 16 Feb 2023 | $3.52 B |
| 15 Feb 2023 | $3.64 B |
| 14 Feb 2023 | $3.59 B |
| 13 Feb 2023 | $3.69 B |
| 10 Feb 2023 | $3.54 B |
| 09 Feb 2023 | $3.54 B |
| 08 Feb 2023 | $3.48 B |
| 07 Feb 2023 | $3.59 B |
| 06 Feb 2023 | $3.58 B |
| 03 Feb 2023 | $3.92 B |
| 02 Feb 2023 | $3.95 B |
| 01 Feb 2023 | $3.77 B |
| 31 Jan 2023 | $3.74 B |
| 30 Jan 2023 | $3.55 B |
| 27 Jan 2023 | $3.59 B |
| 26 Jan 2023 | $3.55 B |
| 25 Jan 2023 | $3.52 B |
| 24 Jan 2023 | $3.62 B |
| 23 Jan 2023 | $3.49 B |
| 20 Jan 2023 | $3.6 B |
| 19 Jan 2023 | $3.62 B |
| 18 Jan 2023 | $3.84 B |
| 17 Jan 2023 | $3.94 B |
| 13 Jan 2023 | $3.93 B |
| 12 Jan 2023 | $3.86 B |
| 11 Jan 2023 | $3.67 B |
| 10 Jan 2023 | $3.53 B |
| 09 Jan 2023 | $3.23 B |
| 06 Jan 2023 | $3.99 B |
| 05 Jan 2023 | $3.96 B |
| 04 Jan 2023 | $4.07 B |
| 03 Jan 2023 | $4.11 B |
| 30 Dec 2022 | $4.3 B |
| 29 Dec 2022 | $4.25 B |
| 28 Dec 2022 | $3.98 B |
| 27 Dec 2022 | $4.04 B |
| 23 Dec 2022 | $4.06 B |
| 22 Dec 2022 | $4.05 B |
| 21 Dec 2022 | $3.93 B |
| 20 Dec 2022 | $3.49 B |
| 19 Dec 2022 | $3.29 B |
| 16 Dec 2022 | $3.37 B |
| 15 Dec 2022 | $3.33 B |
| 14 Dec 2022 | $3.48 B |
| 13 Dec 2022 | $3.48 B |
| 12 Dec 2022 | $3.38 B |
| 09 Dec 2022 | $3.21 B |
| 08 Dec 2022 | $3.35 B |
| 07 Dec 2022 | $3.48 B |
| 06 Dec 2022 | $3.39 B |
| 05 Dec 2022 | $3.37 B |
| 02 Dec 2022 | $3.6 B |
| 01 Dec 2022 | $3.4 B |
| 30 Nov 2022 | $3.41 B |
| 29 Nov 2022 | $3.18 B |
| 28 Nov 2022 | $2.97 B |
| 25 Nov 2022 | $3.13 B |
| 23 Nov 2022 | $3.12 B |
| 22 Nov 2022 | $3.13 B |
| 21 Nov 2022 | $3.16 B |
| 18 Nov 2022 | $3.26 B |
| 17 Nov 2022 | $3.24 B |
| 16 Nov 2022 | $3.36 B |
| 15 Nov 2022 | $3.57 B |
| 14 Nov 2022 | $3.51 B |
| 11 Nov 2022 | $3.66 B |
| 10 Nov 2022 | $3.68 B |
| 09 Nov 2022 | $3.23 B |
| 08 Nov 2022 | $3.53 B |
| 07 Nov 2022 | $3.64 B |
| 04 Nov 2022 | $3.6 B |
| 03 Nov 2022 | $3.62 B |
| 02 Nov 2022 | $3.67 B |
| 01 Nov 2022 | $3.77 B |
| 31 Oct 2022 | $3.69 B |
| 28 Oct 2022 | $3.8 B |
| 27 Oct 2022 | $3.52 B |
| 26 Oct 2022 | $3.47 B |
| 25 Oct 2022 | $3.45 B |
| 24 Oct 2022 | $3.32 B |
| 21 Oct 2022 | $3.54 B |
| 20 Oct 2022 | $3.46 B |
| 19 Oct 2022 | $3.43 B |
| 18 Oct 2022 | $3.72 B |
| 17 Oct 2022 | $3.6 B |
| 14 Oct 2022 | $3.4 B |
| 13 Oct 2022 | $3.43 B |
| 12 Oct 2022 | $3.39 B |
| 11 Oct 2022 | $3.31 B |
| 10 Oct 2022 | $3.23 B |
End of Day market cap according to different sources
Market capitalization for similar companies or competitors
| Name | Market cap | Country |
|---|---|---|
Amylyx Pharmaceuticals, Inc.
MSFT
|
$212.42 M |
 US
|
Annexon, Inc.
MSFT
|
$664.56 M |
US
|
Apellis Pharmaceuticals, Inc.
MSFT
|
$3.35 B |
US
|
BioMarin Pharmaceutical Inc.
MSFT
|
$13.23 B |
US
|
Blueprint Medicines Corporation
MSFT
|
$5.61 B |
US
|
CytomX Therapeutics, Inc.
MSFT
|
$89.84 M |
US
|
Day One Biopharmaceuticals, Inc.
MSFT
|
$1.24 B |
US
|
Incyte Corporation
MSFT
|
$13 B |
US
|
Ionis Pharmaceuticals, Inc.
MSFT
|
$5.98 B |
US
|
IVERIC bio, Inc.
MSFT
|
$5.51 B |
US
|
Karuna Therapeutics, Inc.
MSFT
|
$12.6 B |
US
|
Mirati Therapeutics, Inc.
MSFT
|
$4.12 B |
US
|
ProQR Therapeutics N.V.
MSFT
|
$159.28 M |
 NL
|
Terns Pharmaceuticals, Inc.
MSFT
|
$698.29 M |
US
|
Wave Life Sciences Ltd.
MSFT
|
$1.06 B |
 SG
|